Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.22
+0.17 (2.81%)
At close: Mar 9, 2026, 4:00 PM EDT
5.90
-0.32 (-5.14%)
After-hours: Mar 9, 2026, 6:16 PM EDT
Puma Biotechnology Market Cap
Puma Biotechnology has a market cap or net worth of $316.45 million as of March 9, 2026. Its market cap has increased by 120.83% in one year.
Market Cap
316.45M
Enterprise Value
247.47M
1-Year Change
120.83%
Ranking
Category
Stock Price
$6.22
Market Cap Chart
Since April 24, 2012, Puma Biotechnology's market cap has increased from $280.60M to $316.45M, an increase of 12.78%. That is a compound annual growth rate of 0.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 307.80M | 2.67% |
| Dec 31, 2025 | 299.80M | 100.27% |
| Dec 31, 2024 | 149.70M | -27.33% |
| Dec 29, 2023 | 206.00M | 6.68% |
| Dec 30, 2022 | 193.10M | 55.35% |
| Dec 31, 2021 | 124.30M | -69.53% |
| Dec 31, 2020 | 408.00M | 19.68% |
| Dec 31, 2019 | 340.90M | -56.07% |
| Dec 31, 2018 | 776.00M | -79.08% |
| Dec 29, 2017 | 3.71B | 228.21% |
| Dec 30, 2016 | 1.13B | -55.55% |
| Dec 31, 2015 | 2.54B | -55.43% |
| Dec 31, 2014 | 5.71B | 92.11% |
| Dec 31, 2013 | 2.97B | 452.60% |
| Dec 31, 2012 | 537.50M | 91.55% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relmada Therapeutics | 326.33M |
| Rezolute | 323.04M |
| Avalo Therapeutics | 320.46M |
| Greenwich LifeSciences | 319.90M |
| Protara Therapeutics | 316.16M |
| Nautilus Biotechnology | 312.61M |
| XOMA Royalty | 308.86M |
| Cabaletta Bio | 305.16M |